Fishers Innovation in Biopharma Manufacturing

Scroll Down

Indiana is an attractive potential location for new and growing biopharma manufacturing companies, boasting low facility operating costs, access to highly-educated candidates, and funding opportunities.

In this article, Mayor Scott Fadness explores the benefits that Fishers, a part of the Indianapolis metropolitan area, has to offer biopharma CDMOs. He also highlights the potential for companies already established in the area, like Genezen, to expand, leading to new jobs and fostering growth in the region’s biotech hub.

Read the full article here: Fishers Innovation in Biopharma Manufacturing

You may also be interested in...

Genezen completes cGMP-lentiviral and retroviral vector…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more

Genezen announces launch of Scientific Advisory…

Leading experts in cell and gene therapy will provide guidance to...

Read more

Overcoming development and manufacturing challenges with…

As efficient and effective tools for gene transduction and delivering genes...

Read more

Retroviruses in CAR-T therapies: From gamma…

Introduction In recent years, chimeric antigen receptor T (CAR-T) cells have...

Read more